| International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels WA Catterall, E Perez-Reyes, TP Snutch, J Striessnig Pharmacological reviews 57 (4), 411-425, 2005 | 1651 | 2005 |
| Purification, molecular cloning, and expression of the mammalian sigma1-binding site. M Hanner, FF Moebius, A Flandorfer, HG Knaus, J Striessnig, E Kempner, ... Proceedings of the National Academy of Sciences 93 (15), 8072-8077, 1996 | 1145 | 1996 |
| Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels J Platzer, J Engel, A Schrott-Fischer, K Stephan, S Bova, H Chen, ... Cell 102 (1), 89-97, 2000 | 1078 | 2000 |
| The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential GW Zamponi, J Striessnig, A Koschak, AC Dolphin Pharmacological reviews 67 (4), 821-870, 2015 | 1063 | 2015 |
| Neurobiology of migraine D Pietrobon, J Striessnig Nature Reviews Neuroscience 4 (5), 386-398, 2003 | 784 | 2003 |
| Functional role of L-type Cav1.3 Ca2+ channels in cardiac pacemaker activity ME Mangoni, B Couette, E Bourinet, J Platzer, D Reimer, J Striessnig, ... Proceedings of the National Academy of Sciences 100 (9), 5543-5548, 2003 | 577 | 2003 |
| α1D (Cav1. 3) subunits can form L-type Ca2+ channels activating at negative voltages A Koschak, D Reimer, I Huber, M Grabner, H Glossmann, J Engel, ... Journal of Biological Chemistry 276 (25), 22100-22106, 2001 | 557 | 2001 |
| Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension EAB Azizan, H Poulsen, P Tuluc, J Zhou, MV Clausen, A Lieb, C Maniero, ... Nature genetics 45 (9), 1055-1060, 2013 | 538 | 2013 |
| Pharmacological disruption of calcium channel trafficking by the α2δ ligand gabapentin J Hendrich, AT Van Minh, F Heblich, M Nieto-Rostro, K Watschinger, ... Proceedings of the National Academy of Sciences 105 (9), 3628-3633, 2008 | 500 | 2008 |
| Receptor sites for Ca2+ channel antagonists WA Catterall, J Striessnig Trends in pharmacological sciences 13, 256-262, 1992 | 474 | 1992 |
| CaV1. 3 channels are essential for development and presynaptic activity of cochlear inner hair cells A Brandt, J Striessnig, T Moser Journal of Neuroscience 23 (34), 10832-10840, 2003 | 463 | 2003 |
| The Concise Guide to PHARMACOLOGY 2019/20: Introduction and other protein targets SPH Alexander, E Kelly, A Mathie, JA Peters, EL Veale, JF Armstrong, ... British journal of pharmacology 176, S1-S20, 2019 | 417 | 2019 |
| Functional embryonic cardiomyocytes after disruption of the L-type α1C (Cav 1.2) calcium channel gene in the mouse C Seisenberger, V Specht, A Welling, J Platzer, A Pfeifer, S Kuhbandner, ... Journal of Biological Chemistry 275 (50), 39193-39199, 2000 | 379 | 2000 |
| Loss of Cav1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness SM Baig, A Koschak, A Lieb, M Gebhart, C Dafinger, G Nürnberg, A Ali, ... Nature neuroscience 14 (1), 77-84, 2011 | 363 | 2011 |
| International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels WA Catterall, J Striessnig, TP Snutch, E Perez-Reyes Pharmacological reviews 55 (4), 579-581, 2003 | 348 | 2003 |
| The concise guide to pharmacology 2019/20: Ion channels SPH Alexander, A Mathie, JA Peters, EL Veale, J Striessnig, E Kelly, ... British journal of pharmacology 176, S142-S228, 2019 | 347 | 2019 |
| Familial Hemiplegic Migraine Mutations Change α1ACa2+ Channel Kinetics RL Kraus, MJ Sinnegger, H Glossmann, S Hering, J Striessnig Journal of Biological Chemistry 273 (10), 5586-5590, 1998 | 338* | 1998 |
| Familial hemiplegic migraine mutations increase Ca2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons A Tottene, T Fellin, S Pagnutti, S Luvisetto, J Striessnig, C Fletcher, ... Proceedings of the National Academy of Sciences 99 (20), 13284-13289, 2002 | 337 | 2002 |
| Quantitative proteomics of the Cav2 channel nano-environments in the mammalian brain CS Müller, A Haupt, W Bildl, J Schindler, HG Knaus, M Meissner, ... Proceedings of the National Academy of Sciences 107 (34), 14950-14957, 2010 | 329 | 2010 |
| Structural basis of drug binding to L Ca2+ channels J Striessnig, M Grabner, J Mitterdorfer, S Hering, MJ Sinnegger, ... Trends in pharmacological sciences 19 (3), 108-115, 1998 | 322 | 1998 |
Hartmut GlossmannFull Professor M.D. PhD. Qualified Specialist In Pharmacology,Toxicology and Clinical Pharmacology在 i-med.ac.at 的电子邮件经过验证
